Q/C Technologies, Inc.
Diagnostics company · New York, United States · Nasdaq: QCLS
Q/C Technologies, Inc. is a diagnostics company headquartered in New York, United States. Its earliest recorded incorporation is in 2023. Its shares trade on Nasdaq under the ticker QCLS. It has reported private securities offerings to the US SEC, most recently $7 million sold in a notice filed in 2025.
Q/C Technologies at a glance
What does Q/C Technologies do?
Private fundraising reported to the SEC
10 Form D notices; the most recent reported $7 million sold (2025).
Frequently asked questions about Q/C Technologies
Where is Q/C Technologies headquartered?
Q/C Technologies, Inc. is headquartered in New York, United States.
What does Q/C Technologies do?
Q/C Technologies, Inc. is a diagnostics company. Its SEC industry classification is In Vitro & In Vivo Diagnostic Substances.
Is Q/C Technologies a public company?
Yes. Q/C Technologies, Inc. trades on Nasdaq under the ticker QCLS.
When was Q/C Technologies founded?
The earliest incorporation on record for Q/C Technologies, Inc. is in 2023, according to public company registers.
Similar companies
- Achieve Life Sciences, Inc.Seattle, Washington, United States
- Celldex Therapeutics, Inc.Hampton, New Jersey, United States
- Navidea Biopharmaceuticals, Inc.Dublin, Ohio, United States
- Eyenuk, Inc.Woodland Hills, California, United States
- Lucira Health, Inc.Emeryville, California, United States
- NeuroTrack Technologies, Inc.Redwood City, California, United States
- Biomerica IncIrvine, California, United States
- Meridian Bioscience IncCincinnati, Ohio, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.